Principal Investigator

How to become a Principal Investigator?

A principal investigator is a physician who conducts clinical trial experiments at the study site. The foundation of completing a clinical trial depends on the leadership quality of the principal investigator. In evaluating the novel drug efficacy and safety, a physician comes clinical trial investigator can suggest his/her patients participate in the clinical study by assisting the drug manufacturer. The principal investigator is answerable for all clinical activities at the site and also responsible to ensure the guidelines of the national regulatory agency and Good Clinical Practice (GCP). GCP is an international ethical and scientific quality standard for the design development, conduct, and recording of clinical trials which involve humans. Compliance with GCP assures that the rights, safety and well-being of trial participants are protected, and the results from the clinical trials are credible and accurate.

In association with the principal investigator, clinical trial sites typically have a study coordinator and a clinically-oriented individual. This individual involves in the daily operations of a study and organizes the clinical data to be transferred into Case Report Form (CRF), under the direct supervision of the principal investigator. CRFs are the official records of clinical trial study, and it is the final information considered by the statistical experts to analyze the drug safety and efficacy. As a principal investigator, the individual is responsible for assuring the subjects receive appropriate study-related medical care and to ensure all the study related activities are under the guidelines of good clinical practice.

 

The cutting edge of clinical research is right here

Pepgra investigators work in every therapeutic area across all phases of the drug investigation. As a clinical trial investigator, you may play a vital role in developing medicinal therapies that benefit all patients, and that will help us improve healthcare.

Being part of an extensive investigator network, you may have the opportunity to;

  • Work with drugs that are on clinical phase and conduct cutting edge research in your therapeutic area
  • Exchange ideas with other clinical investigators and get a chance to be a co-author for an article
  • Gain recognition and professional development in your field of research
  • Gain the benefit of additional revenue

 

Key therapeutic areas:

  • Cardiovascular
  • Central Nervous System
  • Dermatology
  • Endocrinology & Metabolic Disease
  • Gastroenterology
  • Gynecology
  • Infectious Diseases
  • Neuroscience
  • Nephrology, Renal, & Urology
  • Oncology
  • Ophthalmology
  • Pain Management
  • Respiratory & Immuno-inflammatory
  • Vaccine & Virology

 

Why partner with us?

  • We provide our co-participating physicians with an opportunity to be involved in a full range of clinical trials includes medicinal drugs, nutraceuticals, medical device and IoT.
  • Our clinical trial studies incorporate the full range of services from clinical study design to bio-analytics, pre-approval and post-marketing services

 

Resources required for conducting clinical trials studies

Conducting clinical trial requires a large number of resources which includes;

  • Electronic equipment such as a computer with internet access, telephone, and fax machine for patient scheduling and study correspondence
  • Examination rooms (to conduct physical test and discussions with study subjects)
  • A storage area for study materials, clinical medicine and laboratory materials
  • Adjustable refrigerator/freezer to store lab samples and medication
  • A secure storage area to maintain clinical trial records
  • Adequate working space for on-site visits from regulatory authorities
  • The principal investigator and support staff should be available to the sponsor company anytime to review associated study issues and answer pertinent clinical trial-related questions

 

How to be involved in clinical trials

There are many options for volunteers to enter the clinical research field, and it is essential to be experienced in the regulatory requirements in the conduct of clinical trials.

  • Through Contract Research Organizations (CROs), contract pharmaceutical and biotechnology industries
  • Advertise your services on the internet and in industrial publications
  • Attend annual meetings of the Association of Clinical Research Professionals (ACRP) and Drug Information Association (DIA)
  • Contact a Site Management Organization (SMO);
    • An SMO is a centralized sponsoring organization for several clinical sites and provides physicians with a fantastic opportunity to gain research experience.

 

Are you interested in becoming a principal investigator for Pepgra?

Pepgra is looking for an experienced physician to become clinical investigators potentially, and we encourage the interested physicians to be a part of clinical research and possibly co-participate in the clinical trial study in our key therapeutic areas. If you are specialized in one of these areas, submit your information and contact details below. If Pepgra projects match your expertise, you may be contacted by a Pepgra representative for further evaluation. A member from Pepgra clinical staff may travel to your site and collect information about you and your support staff’s clinical research experience. Further, the staff may inspect your medical facilities and assess the overall ability to conduct the clinical investigation effectively and successfully. Based on the results of the meeting, you will be notified if you have been chosen to participate in the study.

Principal Investigators make profound contributions to improving healthcare through clinical research


Positively impact the health of millions, including friends, family, and future generations


Improve and educate yourself about your own health


Gain access to quality medical care and medications not available through other means


Receive financial compensation for time and travel

Register your site with us to be considered for ongoing and future clinical trials